A new national study is looking at how well COVID-19 vaccines work in vulnerable and immunocompromised Canadians.
Vaccine immunogenicity is being studied among this population, meaning: Does this vaccine create an immune response? Another team within the study is focusing on blood cancer patients.
Global's Su-Ling Goh has the details.
For more info, please go to https://globalnews.ca/tag/coronavirus/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#COVID19 #Vaccines #Study #GlobalNews
Vaccine immunogenicity is being studied among this population, meaning: Does this vaccine create an immune response? Another team within the study is focusing on blood cancer patients.
Global's Su-Ling Goh has the details.
For more info, please go to https://globalnews.ca/tag/coronavirus/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#COVID19 #Vaccines #Study #GlobalNews
- Category
- U.S. & Canada
- Tags
- global news, suh-ling goh, study
Sign in or sign up to post comments.
Be the first to comment